{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR337/036/SRR33789436/SRR33789436_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR337/037/SRR33789437/SRR33789437_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR337/036/SRR33789436/SRR33789436_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR337/037/SRR33789437/SRR33789437_1.fastq.gz"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Institute for Cancer and Genomic Sciences, University of Birmingham"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1271021"],"scientific_name":["Homo sapiens"],"tag":["xref:PubMed:40593493"],"long_description":["Myelodisplastic syndromes are a oligoclonal disease starting at the level of the stem/progenitor compartment. We used ATACseq to determine changes in chromating landscape between MDS low and high risk samples. Overall design: ATAC-seq of CD34+ HSCPs from MDS patients before and after disease progression"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Chromatin accessibility of hematopoietic stem/progenitor cells (HSPCs) derived from MDS patients before and after disease progression","description":"Chromatin accessibility of hematopoietic stem/progenitor cells (HSPCs) derived from MDS patients before and after disease progression","dates":{"last_updated":"2025-09-24","first_public":"2025-06-04"},"accession":"PRJNA1271021","cross_references":{"GEO":["GSE298729"],"taxon":["9606"],"PubMed":["40593493"]}}